Predicting Adverse Drug Events Using Pharmacological Network Models
暂无分享,去创建一个
Ben Y. Reis | B. Reis | A. Cami | A. Arnold | S. Manzi
[1] D. Butina,et al. Predicting ADME properties in silico: methods and models. , 2002, Drug discovery today.
[2] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[3] John C. Dearden,et al. In silico prediction of drug toxicity , 2003, J. Comput. Aided Mol. Des..
[4] Clare Ellis. FDA alerts asthmatics to drug safety risk , 2003, Nature Reviews Drug Discovery.
[5] J. Kramer,et al. The role of investigative molecular toxicology in early stage drug development , 2003, Expert opinion on drug safety.
[6] D. Thompson,et al. Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.
[7] Ben van Ommen,et al. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology , 2005, Expert review of proteomics.
[8] E. Butcher. Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.
[9] A. Fliri,et al. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. , 2005, Journal of medicinal chemistry.
[10] A. Fliri,et al. Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.
[11] Alasdair Breckenridge,et al. Monitoring the safety of licensed medicines , 2005, Nature Reviews Drug Discovery.
[12] W. DuMouchel,et al. Comparative Performance of Two Quantitative Safety Signalling Methods , 2006, Drug safety.
[13] S. Frantz. Pharma's year of trouble and strife , 2006, Nature Reviews Drug Discovery.
[14] S. Ekins,et al. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling , 2007, British journal of pharmacology.
[15] M. Kulldorff,et al. Early detection of adverse drug events within population‐based health networks: application of sequential testing methods , 2007, Pharmacoepidemiology and drug safety.
[16] J. Kramer,et al. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.
[17] Jon M. Kleinberg,et al. The link-prediction problem for social networks , 2007, J. Assoc. Inf. Sci. Technol..
[18] A. Fliri,et al. Analysis of System Structure–Function Relationships , 2007, ChemMedChem.
[19] M. Newman,et al. Hierarchical structure and the prediction of missing links in networks , 2008, Nature.
[20] 2007: Spotlight on drug safety , 2008, Nature Reviews Drug Discovery.
[21] Martina Morris,et al. A statnet Tutorial. , 2008, Journal of statistical software.
[22] M. Fielden,et al. The role of early in vivo toxicity testing in drug discovery toxicology. , 2008, Expert opinion on drug safety.
[23] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[24] P. Bork,et al. Large‐scale prediction of drug–target relationships , 2008, FEBS letters.
[25] Stephen T. C. Wong,et al. The knowledge-integrated network biomarkers discovery for major adverse cardiac events. , 2008, Journal of proteome research.
[26] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[27] D. Hunter,et al. Goodness of Fit of Social Network Models , 2008 .
[28] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[29] M. Fielden,et al. The role of early in vivo toxicity testing in drug discovery toxicology , 2008 .
[30] A. Chiang,et al. Data‐Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events , 2009, Clinical pharmacology and therapeutics.
[31] G Niklas Norén,et al. Modern methods of pharmacovigilance: detecting adverse effects of drugs. , 2009, Clinical medicine.
[32] K. Azzaoui,et al. In vitro safety pharmacology profiling: what else beyond hERG? , 2009, Future medicinal chemistry.
[33] Ravi Iyengar,et al. Network analyses in systems pharmacology , 2009, Bioinform..
[34] M. Milik,et al. Mapping adverse drug reactions in chemical space. , 2009, Journal of medicinal chemistry.
[35] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[36] Von-Wun Soo,et al. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods , 2010, Artif. Intell. Medicine.
[37] Roded Sharan,et al. An Algorithmic Framework for Predicting Side-Effects of Drugs , 2010, RECOMB.
[38] J. Aronson,et al. EIDOS: a mechanistic classification of adverse drug effects. , 2010, Drug safety.
[39] Roded Sharan,et al. Combining Drug and Gene Similarity Measures for Drug-Target Elucidation , 2011, J. Comput. Biol..
[40] Seth I. Berger,et al. Role of systems pharmacology in understanding drug adverse events , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.